GAMMA Investing LLC Grows Stock Holdings in Roche Holding AG $RHHBY

GAMMA Investing LLC raised its position in Roche Holding AG (OTCMKTS:RHHBY) by 25.3% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 16,101 shares of the company’s stock after acquiring an additional 3,251 shares during the quarter. GAMMA Investing LLC’s holdings in Roche were worth $656,000 at the end of the most recent quarter.

Other hedge funds have also recently modified their holdings of the company. Rhumbline Advisers increased its position in shares of Roche by 7.4% in the first quarter. Rhumbline Advisers now owns 107,252 shares of the company’s stock valued at $4,413,000 after acquiring an additional 7,374 shares during the period. Altrius Capital Management Inc increased its position in shares of Roche by 3.6% in the first quarter. Altrius Capital Management Inc now owns 189,993 shares of the company’s stock valued at $7,818,000 after acquiring an additional 6,545 shares during the period. Everett Harris & Co. CA purchased a new position in shares of Roche in the first quarter valued at about $445,000. Bard Financial Services Inc. increased its position in shares of Roche by 25.3% in the first quarter. Bard Financial Services Inc. now owns 138,900 shares of the company’s stock valued at $5,716,000 after acquiring an additional 28,050 shares during the period. Finally, Riverbridge Partners LLC increased its position in shares of Roche by 6.7% in the first quarter. Riverbridge Partners LLC now owns 37,826 shares of the company’s stock valued at $1,557,000 after acquiring an additional 2,381 shares during the period.

Roche Trading Down 1.7%

RHHBY stock opened at $41.06 on Thursday. The firm’s 50-day moving average price is $40.51 and its two-hundred day moving average price is $40.32. Roche Holding AG has a 12-month low of $34.10 and a 12-month high of $44.31. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.20 and a current ratio of 1.48.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.